Skip to content

Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation

Clinical Utility of a Predictive Model of Placental Insufficiency

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07144839
Acronym
PRACTICE
Enrollment
640
Registered
2025-08-28
Start date
2025-09-18
Completion date
2029-06-30
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placental Insufficiency, Stillbirth

Brief summary

This is a prospective observational study with the goal of developing and assessing a predictive model of placental insufficiency.

Detailed description

Pregnant study participants will be recruited and monitored throughout pregnancy with ultrasound and blood draws, and delivery and neonatal data up to 28 days following birth. This data will be used to develop a model to predict placental insufficiency.

Interventions

OTHERData Collection Throughout Pregnancy and Delivery

Participants will receive monitoring by ultrasound and blood tests at three time points during pregnancy, and delivery and neonatal data will be collected.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Oregon Health and Science University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant * Age 15 or older * No known major fetal anatomic or genetic abnormalities * Singleton gestation * Planning to deliver at Oregon Health & Science University * Prior to 22 weeks' gestation

Exclusion criteria

* Decisional impairment * Multiple gestation * Known fetal growth restriction or major congenital anomaly * Inability to consent * Inability to attend study visits

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with placental insufficiency compositeAt time of delivery to 28 days following deliveryThe composite is made of the following: stillbirth and neonatal death, severe forms of hypertensive disease, placental abruption, birthweight below the 3rd percentile, umbilical cord arterial pH\<7, and/or placental primary indication for delivery (FGR, oligohydramnios, abnormal fetal testing)

Countries

United States

Contacts

Primary ContactWomen's Health Research Unit Department of Ob/Gyn
whru@ohsu.edu503-494-3666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026